Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Disclosure of Changes in Director's Interest-Mark Ryan

Issuer & Securities

Issuer/ Manager
CLEARBRIDGE HEALTH LIMITED
Securities
CLEARBRIDGE HEALTH LIMITED - SG1EB6000000 - 1H3
Stapled Security
No

Announcement Details

Announcement Title
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
Date &Time of Broadcast
01-Jul-2020 18:04:54
Status
New
Announcement Sub Title
Disclosure of Changes in Director's Interest-Mark Ryan
Announcement Reference
SG200701OTHRFK77
Submitted By (Co./ Ind. Name)
Chen Johnson
Designation
Chairman, Non-Executive Non-Independent Director
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
This announcement has been prepared by Clearbridge Health Limited (the "Company") and has been reviewed by the Company's sponsor, United Overseas Bank Limited (the "Sponsor"), for compliance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Chia Beng Kwan, Senior Director, Equity Capital Markets, who can be contacted at 80 Raffles Place, #03-03 UOB Plaza 1, Singapore 048624, telephone: +65 6533 9898.

Additional Details

Person(s) giving notice
Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)
Date of receipt of notice by Listed Issuer
01/07/2020

Attachments

FORM 1-FINAL_MARK RYAN.pdf
if you are unable to view the above file, please click the link below.
_FORM 1-FINAL_MARK RYAN.pdf
Total size =151K